Literature DB >> 15702294

[Prolongation of latency or overall treatment time by unplanned radiation pauses. The clinical importance of compensation].

Thomas Herrmann1, Michael Baumann.   

Abstract

BACKGROUND AND
PURPOSE: Local tumor control after radiotherapy does not only depend on total dose, dose per fraction and physical parameters but also on the time interval between surgery and begin of radiotherapy and on overall time of fractionated irradiation. This study summarizes the evidence for an impact of delay and overall time of radiotherapy on locoregional tumor control.
METHODS: Published reports of the last 30 years were reviewed for evidence of a time factor, i.e., for an influence of overall treatment time on local tumor control. Overall, 33 nonrandomized studies and twelve randomized trials addressing this question were identified.
RESULTS: Prolongation of waiting time between surgery and radiotherapy, dependent on tumor type and residual burden, decreases local control. Postoperative radiotherapy should be initiated early, whenever medically appropriate. Almost all nonrandomized and randomized trials indicate that prolongation of overall time of fractionated irradiation decreases local tumor control, particularly of squamous cell carcinoma of the head and neck and cervix, but also of non-small cell and small cell lung cancer. In these tumors prolongation of overall treatment time by 1 week results in a decrease of local control between 1-16%.
CONCLUSION: Prescription of radiotherapy may not be limited to total dose and dose per fraction, but needs to include the parameter overall treatment time. Unscheduled treatment interruptions such as holidays, machine breakdown or patient-related factors, leading to protraction of the overall treatment time, decrease the chance of cure for the patient. Therefore, unplanned gaps need to be compensated by appropriate measures such as additional fractions at weekends or by applications of a second fraction per day.

Entities:  

Mesh:

Year:  2005        PMID: 15702294     DOI: 10.1007/s00066-005-1331-9

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  10 in total

1.  Effects of bone marrow or mesenchymal stem cell transplantation on oral mucositis (mouse) induced by fractionated irradiation.

Authors:  M Schmidt; J Haagen; R Noack; A Siegemund; P Gabriel; W Dörr
Journal:  Strahlenther Onkol       Date:  2014-01-24       Impact factor: 3.621

2.  Potential clinical predictors of outcome after postoperative radiotherapy of non-small cell lung cancer.

Authors:  R Bütof; K Kirchner; S Appold; S Löck; A Rolle; G Höffken; M Krause; M Baumann
Journal:  Strahlenther Onkol       Date:  2014-01-12       Impact factor: 3.621

3.  [Concurrent once-daily or twice-daily chemoradiotherapy in limited-stage small-cell lung cancer?]

Authors:  Susanne Frosch; Esther G C Troost
Journal:  Strahlenther Onkol       Date:  2018-01       Impact factor: 3.621

4.  Modulation of radiation-induced oral mucositis by pentoxifylline: preclinical studies.

Authors:  Sylvia Gruber; Margret Schmidt; Eva Bozsaky; Kathrin Wolfram; Julia Haagen; Bettina Habelt; Martin Puttrich; Wolfgang Dörr
Journal:  Strahlenther Onkol       Date:  2014-10-29       Impact factor: 3.621

5.  Competing causes of death and medical comorbidities among patients with human papillomavirus-positive vs human papillomavirus-negative oropharyngeal carcinoma and impact on adherence to radiotherapy.

Authors:  Clayton B Hess; Dominique L Rash; Megan E Daly; D Gregory Farwell; John Bishop; Andrew T Vaughan; Machelle D Wilson; Allen M Chen
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2014-04       Impact factor: 6.223

6.  Impact of Time Factors on Outcome in Patients with Head and Neck Cancer Treated with Definitive Radio(Chemo)Therapy.

Authors:  Sören Dahlke; Diana Steinmann; Hans Christiansen; Martin Durisin; Andre Eckardt; Gerd Wegener; Michael Bremer; Andreas Meyer
Journal:  In Vivo       Date:  2017 Sep-Oct       Impact factor: 2.155

7.  The effects of tea extracts on proinflammatory signaling.

Authors:  Frank Pajonk; Anja Riedisser; Michael Henke; William H McBride; Bernd Fiebich
Journal:  BMC Med       Date:  2006-12-01       Impact factor: 8.775

8.  Impact of waiting time after surgery and overall time of postoperative radiochemotherapy on treatment outcome in glioblastoma multiforme.

Authors:  Annekatrin Seidlitz; Timo Siepmann; Steffen Löck; Tareq Juratli; Michael Baumann; Mechthild Krause
Journal:  Radiat Oncol       Date:  2015-08-16       Impact factor: 3.481

9.  Benefit of percutaneous endoscopic gastrostomy in patients undergoing definitive chemoradiotherapy for locally advanced nasopharyngeal carcinoma.

Authors:  Yun Xu; Qiaojuan Guo; Jin Lin; Bijuan Chen; Jiangmei Wen; Tianzhu Lu; Yuanji Xu; Mingwei Zhang; Jianji Pan; Shaojun Lin
Journal:  Onco Targets Ther       Date:  2016-11-04       Impact factor: 4.147

10.  Protective effects of systemic dermatan sulfate treatment in a preclinical model of radiation-induced oral mucositis.

Authors:  Sylvia Gruber; Katharina Frings; Peter Kuess; Wolfgang Dörr
Journal:  Strahlenther Onkol       Date:  2018-03-01       Impact factor: 3.621

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.